Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Hair growth phase in mice weakens certain immune responses.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Immunotherapy can help treat severe alopecia areata.

A woman with lupus developed a rare skin condition, which improved with increased medication.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Innate lymphoid cells type 1 may contribute to alopecia areata.

A mutation in the IL2RA gene increases the risk of alopecia areata.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Rituximab improved her dermatomyositis better than usual treatments.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Many children with alopecia areata also have other autoimmune diseases.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

The role of γδT-cells in causing alopecia areata remains unclear.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Higher inflammation markers are linked to more severe alopecia areata.

The woman's skin condition persisted for 20 years despite treatments.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.